"Survivability Data Adds to Urgency to Make AMX0035 Available…"
Connecting ALS - Een podcast door ALS Association
Categorieën:
Welcome to Connecting ALS. This week, Mike and Jeremy talk to Dr. Sabrina Paganoni, co-director of MGH Neurological Clinical Research Institute and principal investigator of the CENTAUR trial evaluating the effects of Amylyx Pharmaceutical’s AMX0035 on people living with ALS.
